A multimodal prenatal diagnostic approach for Neurocutaneous Melanosis (NCM), integrating ultrasound, MRI, fetoscopy, and genetic testing, in a case with negative NRAS/BRAF mutations. The gene discussed is NRAS; the disease is neurocutaneous melanocytosis.